Kilman Appointed to Leadership in Florida State Hispanic Chamber of Commerce
14 August 2017
Partner Jonathan Kilman has been elected to the Florida State Hispanic Chamber of Commerce’s Board of Governors and its newly formed Strategy Committee, according to Florida Trend.
“Corporate leaders cannot map out the future of Florida without considering the extraordinary impact and contribution of the State’s Hispanic business community. The Strategy Committee will synergize our state’s talent, energy and commerce to grow Florida’s economy. Not only is Florida the recognized gateway to the Americas, but we have become the landing point of choice for Hispanic people looking to pursue their hopes and dreams in our great nation,” Kilman said of his appointment to the Chamber.
Read more about Kilman’s appointment here.
“Corporate leaders cannot map out the future of Florida without considering the extraordinary impact and contribution of the State’s Hispanic business community. The Strategy Committee will synergize our state’s talent, energy and commerce to grow Florida’s economy. Not only is Florida the recognized gateway to the Americas, but we have become the landing point of choice for Hispanic people looking to pursue their hopes and dreams in our great nation,” Kilman said of his appointment to the Chamber.
Read more about Kilman’s appointment here.
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”